title: Editorial Comment from Dr Ishizuka to effect of intrathecal administration of E-series prostaglandin 1 receptor antagonist in a cyclophosphamide-induced cystitis rat model.
authors.forename: Osamu
authors.initials: O
authors.lastname: Ishizuka
mesh_terms: D000818:Animals; D001643:Bridged Bicyclo Compounds / Q000494:pharmacology*; D002208:Caproates / Q000494:pharmacology*; D003520:Cyclophosphamide / Q000009:adverse effects / Q000494:pharmacology; D003556:Cystitis / Q000139:chemically induced / Q000188:drug therapy*; D004195:Disease Models, Animal; D005260:Female; D007278:Injections, Spinal; D011897:Random Allocation; D051381:Rats; D017208:Rats, Wistar; D058306:Receptors, Prostaglandin E, EP1 Subtype / Q000037:antagonists & inhibitors*; D012680:Sensitivity and Specificity; D016896:Treatment Outcome; D053201:Urinary Bladder, Overactive / Q000517:prevention & control
chemical_list: D001643:Bridged Bicyclo Compounds; D002208:Caproates; C122148:ONO 8711; D058306:Receptors, Prostaglandin E, EP1 Subtype; D003520:Cyclophosphamide